# Zaleplon in HIV Patients With Depression

> **NCT03489304** · PHASE2 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 20 (actual)

## Conditions studied

- HIV/AIDS
- Clinical Depression

## Interventions

- **DRUG:** Zaleplon

## Key facts

- **NCT ID:** NCT03489304
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04-03
- **Primary completion:** 2015-02-04
- **Final completion:** 2015-02-04
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03489304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03489304, "Zaleplon in HIV Patients With Depression". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03489304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*